ArticlePharmacotherapy2018

Incidence of and Risk Factors for Severe Adverse Events in Elderly Patients Taking Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers after an Acute Myocardial Infarction.

Gang Fang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.